SCHEMBL6173741

SCHEMBL6173741

O=C1NC(CO)CN1C(=O)OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
GAA P10253 1/20 0.50
MAPK1 P28482 1/20 0.50
HTR2C P28335 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP2C19 P33261 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PSEN1 P49768 2/20 0.43
PSEN2 P49810 2/20 0.43
APH1B Q8WW43 2/20 0.43
NCSTN Q92542 2/20 0.43
APH1A Q96BI3 2/20 0.43
PSENEN Q9NZ42 2/20 0.43
GLA P06280 1/20 0.42
CTRB1 P17538 1/20 0.42
P2RX4 Q99571 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20701414 0.82 NPC1 (0.51) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL8978249 0.82 HTR2C (0.56) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL17481627 0.81 NPC1 (0.50) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL7503107 0.81 SMN1; SMN2 (0.49) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL7503113 0.81 SMN1; SMN2 (0.49) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL28477269 0.81 SMN1; SMN2 (0.49) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL1929718 0.78 HTR2C (0.48) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL29235094 0.75 NPC1 (0.61) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL20701799 0.74 FAAH (0.48) NPC1RAB9ASMN1; SMN2GAAMAPK1
SCHEMBL20701800 0.74 FAAH (0.48) NPC1RAB9ASMN1; SMN2GAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1027051-B1 ANTITHROMBOTIC AGENTS LILLY CO ELI (US) 2005-01-05 EP disclosed
US-6391901-B1 Thrombin inhibitors ELI LILLY AND COMPANY 2002-05-21 US disclosed
EP-1027051-A4 ANTITHROMBOTIC AGENTS LILLY CO ELI (US) 2001-03-07 EP disclosed
EP-1027051-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 2000-08-16 EP disclosed
WO-1998048804-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 1998-11-05 WO disclosed